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Lion lentivirus (LLV; also known as feline immunodeficiency virus of lion, Panthera leo [FIVPle]) is
present in free-ranging and captive lion populations at a seroprevalence of up to 100%; however, clinical
signs are rarely reported. LLV displays up to 25% interclade sequence diversity, suggesting that it has
been in the lion population for some time and may be significantly host adapted. Three captive lions
diagnosed with LLV infection displayed lymphocyte subset alterations and progressive behavioral, loco-
motor, and neuroanatomic abnormalities. No evidence of infection with other potential neuropathogens
was found. Antemortem electrodiagnostics and radiologic imaging indicated a diagnosis consistent with
lentiviral neuropathy. PCR was used to determine a partial lentiviral genomic sequence and to quantify
the proviral burden in eight postmortem tissue specimens. Phylogenetic analysis demonstrated that the
virus was consistent with the LLV detected in other captive and free-ranging lions. Despite progressive
neurologic signs, the proviral load in tissues, including several regions of the brain, was low; furthermore,
gross and histopathologic changes in the brain were minimal. These findings suggest that the symptoms
in these animals resulted from nonspecific encephalopathy, similar to human immunodeficiency virus,
FIV, and simian immunodeficiency virus (SIV) neuropathies, rather than a direct effect of active viral
replication. The association of neuropathy and lymphocyte subset alterations with chronic LLV infection
suggests that long-term LLV infection can have detrimental effects for the host, including death. This is
similar to reports of aged sootey mangabeys dying from diseases typically associated with end-stage SIV
infection and indicates areas for further research of lentiviral infections of seemingly adapted natural
hosts, including mechanisms of host control and viral adaptation.
Lion lentivirus (LLV; also known as feline immunodefi-
ciency virus [FIV] of lion, Panthera leo [FIVPle]) is an FIV that
is related to yet distinct from the domestic cat (Felis catus) FIV
(4, 52). LLV is present in free-ranging prides at seroprevalence
rates that approach 100% and is commonly detected in captive
lion (Panthera leo) populations, suggesting that it is efficiently
transmitted (4, 19, 22, 25, 32, 42, 50, 52, 53). Five distinct
heterogeneous clades of LLV have been identified on the basis
of sequence analysis of a conserved region of the pol gene. Up
to 25% sequence diversity between clades has been noted in
this highly conserved region of the lentiviral genome, suggest-
ing that, for such genetic heterogeneity to occur, this virus has
infected the lion population for a considerable time (4, 52, 53).
LLV apparently causes little or no clinical disease in free-ranging
lions, although clinical signs and immunopathology reminiscent of
lentiviral infection have been reported in geriatric captive ani-
mals, perhaps due to their longer life spans and/or stress-related
cofactors in these cohorts (6, 19, 22, 41, 42).
The effects of FIV on domestic cats are well documented
and most notably include infection of CD4 T cells with sub-
sequent CD4-CD8 inversion and immunosuppression, making
it a useful model for the pathogenesis of human immunodefi-
ciency virus (HIV) infection (13, 17). FIV also induces a len-
tiviral encephalopathy and has been used in this capacity as a
model for HIV neurologic disease (36–41).
Information on the tissue tropism, viral kinetics, and patho-
genesis of LLV is much more limited in scope. Lymphoma in
one lion and retinitis in several LLV-infected lions have been
described, and T-cell-subset profile alterations have been sub-
stantiated in several captive lions (6, 19, 22, 42) and in free-
ranging individuals (46). This study describes the neurologic
manifestations of lion lentivirus infection in three captive lions,
which were found to be analogous to FIV and HIV neuro-
pathies, and characterizes the viral distribution and selected
immunological phenotypes associated with LLV infection. These
findings illustrate an association between chronic LLV infec-
tion and clinical neurologic disease in lions, despite a low viral
load, analogous to the lentiviral encephalopathy in cats and
humans, and also provides insights into the viral load and
distribution that contribute to the relatively low level of patho-
genicity of this virus for its natural host.
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MATERIALS AND METHODS
Animals. Two adult female LLV-seropositive lions (lions EL and DJ) and one
adult male LLV-seropositive lion (lion TT) from the Columbus Zoo in Colum-
bus, OH, were evaluated in this study. The approximate ages of lions EL, DJ, and
TT at the initiation of these studies were 19, 17, and 15 years, respectively. Three
seronegative lions, one female and two males, ages 18, 21, and 23 months, served
as uninfected control blood donors. All animals were housed at the Columbus
Zoo in two separate exhibits. The three infected lions were physically separated
from the control lions by approximately 1/4 mile. No utensils or equipment were
shared between the exhibits. All lions were fed a commercial carnivore diet (5 to
9 pounds; Zoo Carnivore Diet; Dallas Crown Inc., Kaufman, TX) daily, with a
fast day on Sunday. Both infected female lions were euthanized because of
progressive physical deterioration, while the male died due to a severe progres-
sive anemia. The studies described here were approved by the Ohio State Uni-
versity, the Columbus Zoo, and the Colorado State University Animal Care and
Use Committees.
Physical examination and observation. General health evaluation consisted of
serum biochemical profile analysis, complete blood count with differential anal-
ysis, platelet count, urinalysis, hemostasis screening (one-stage prothrombin
time, activated partial thromboplastin time, fibrinogen, fibrin degradation prod-
ucts), and thoracic radiographs performed at the Ohio State University Veteri-
nary Teaching Hospital (Columbus, OH). Observational changes in the behav-
iors and activities of lions TT and EL were assessed on a monthly basis by
Columbus Zoo animal handlers. Selected elapsed-time videos were reviewed by
a veterinary neurologist (M.D.P.). The frequencies of behavior changes were
scored on a discrete scale from 0 to 3, as follows: 0, normal behavior (normal
mentation and appetite); 1, mild behavior change (very slight dysphagia and a
slight change in normal behavior, such as a delay in shifting cages); 2, moderate
behavior change (obvious dysphagia not impeding consumption of diet, behavior
change in normal routine shifting or training, slight imbalances when jumping or
climbing, and/or “star gazing” [explained below] that was easily interrupted); and
3, severe change (agitation in a normally calm animal, star gazing that was
difficult to interrupt, excessive stereotypic behavior, dysphagia that significantly
increased the time required to consume food, and/or obvious incoordination).
Electrodiagnostic examination. Quantitative neurophysiologic changes were
analyzed by using auditory evoked potential (AEP) and quantitative electroen-
cephalography (QEEG) tests performed while the animals were under isoflurane
gas anesthesia by use of the Biologic Brain Atlas system (Biologic System Co.,
Mundelein, IL). Venous blood gas, pulse oximetry, and end-tidal partial CO2
pressure were monitored to stabilize the blood pH and ensure constant levels of
arterial oxygen and carbon dioxide tension to remove confounding variables of
the QEEG. The QEEG data were analyzed by comparison of the spectral
analysis results for the infected and the control animals within each group and
between groups (36). Spectral differences between hemispheres for each indi-
vidual recording were evaluated during each recording session. Electrode place-
ment, signal filtering, and averaging and data analysis for AEP were performed
as described previously (39) by using a computerized electrodiagnostic system
(Neuropak 4; Nihon-Kodon, Irvine, CA).
Neuroimaging. Magnetic resonance imaging (MRI) of the brain was per-
formed with one affected female lion (lion EL) by using a 0.3-T open-magnet
MRI system (AIRIS; Hitachi Medical Systems America Inc., Twinsburg, OH).
The lion was positioned in sternal recumbency while she was under general
isoflurane anesthesia. The MRI study included transverse dual-spin echo proton
density and spin-spin relaxation time (T2)-weighted images (repetition time 
3,170 ms, time to echo  25 and 90 ms, slice thickness  5 mm) and pre- and
postcontrast sagittal, dorsal, and transverse spin-lattice relaxation time (T1)-
weighted images (repetition time  600 ms, time to echo  25 ms, slice
thickness  5 mm). The contrast medium was intravenously administered
gadopentetate-dimeglumine (0.2 mg/kg of body weight; Magnevist; Berlex
Laboratories, Wayne, NJ).
Lymphocyte phenotyping. The immune profiles of all infected lions were
monitored by lymphocyte subtype analysis and determination of total granulo-
cyte counts at four time points during one 9-month period after clinical signs
were recognized. Lymphocyte subpopulations were enumerated by immuno-
staining and flow cytometry with an Epics Elite flow cytometer (Beckman
Coulter, Inc., Miami, FL; Department of Veterinary Biosciences, The Ohio State
University, Columbus, OH). Mouse anti-cat CD8 and CD4 (Southern Biotech,
Birmingham, AL) and CD5 (clone f43, Abcam, Cambridge, MA; (1) were used
to stain fresh whole blood, as described previously (36). The lymphocyte totals,
expressed as pan-T, CD4, and CD8 lymphocytes, were determined by multi-
plying the percentage of positively immunostaining populations by the complete
blood count lymphocyte values.
Serology. The titers of antibodies to LLV in serum were determined by im-
munoblotting, as described previously (55). Feline leukemia virus titers were
determined by enzyme-linked immunosorbent assay (Ohio State University Vet-
erinary Teaching Hospital Clinical Laboratory). Assays for the detection of
serum and cerebrospinal antibodies to canine distemper virus, feline infectious
peritonitis virus, Toxoplasma gondii, Neospora caninum, and cryptococcosis were
performed by the Laboratory Corporation of America (Dublin, OH).
Postmortem evaluation. The animals were subjected to a postmortem exam-
ination immediately following euthanasia, and gross lesions were noted at that
time. At necropsy, samples were collected from the following tissues: brain,
pituitary, meninges, trigeminal ganglia, spinal cord, radial nerve, eye, pancreas,
liver, gall bladder, stomach, small and large intestines, lymph nodes, heart, lungs,
kidney, thyroid, parathyroid, adrenal gland, skeletal muscle, tongue, tendon,
bone marrow, and skin. Samples of each tissue were fixed in 10% neutral
buffered formaldehyde for 4 days and were then embedded in paraffin. Sections
of 5 to 6 m from each tissue were stained with hematoxylin and eosin and
examined on an Olympus BX41 microscope equipped with a Q-Color-3 camera
and corresponding software (Olympus, Center Valley, PA).
Virology. (i) In vitro propagation. One million peripheral blood mononuclear
cells (PBMCs) from lions TT and EL were collected at three time points and
cocultivated with an equal number of the following cell types by standard tech-
niques: domestic cat PBMCs, naı¨ve lion PBMCs, naı¨ve puma (Puma concolor)
PBMCs, the 3201 interleukin-2-independent feline lymphoid cell line, the GS-
355 feline astrocyte cell line, and Crandall feline kidney cells (CRFKs; CCL-94,
American Type Culture Collection, Manassas, VA) (55). Supernatants were
collected biweekly and were assayed for reverse transcriptase (RT) activity be-
tween days 14 and 35 of culture by using a microtiter RT assay (18, 58). FIV-
infected CRFK supernatants and uninfected cell cultures served as positive and
negative controls, respectively.
(ii) DNA sequencing. DNA was extracted from the lion TT PBMCs and
subjected to degenerate PCR with consensus primers to amplify a 385-bp se-
quence in pol corresponding to the FIV Petaluma coordinates from base pairs
2529 to 2934 (4). The PCR products were cloned by using a Topo TA kit
(Invitrogen, Carlsbad, CA) and were sequenced by Macromolecular Resources
(Fort Collins, CO). Nested primers were generated from this lion TT pol se-
quence (outer forward primer, 5-ACAGAAAAGGGTGCAGAAG; outer re-
verse primer, 5-GGCAAAGAACACCATACAAA; inner forward primer, 5-G
GGTGCAGAAGTTCAAT; inner reverse primer, 5-TTATTCACCTTCGGTA
AAGT). The outer and the inner primers amplified fragments of 180 bp and 133
bp, respectively. These primers were used to generate PCR products from lion
EL, which were similarly cloned and sequenced.
(iii) Phylogenetic analysis. A total of 350 bp of the amplified sequence was
aligned to the LLV sequences of known subtype by use of the ClustalX program.
Two domestic cat FIV sequences were included as the outgroup. Phylogenetic
reconstruction was performed by using PAUP, version 4.0 (51). The minimum-
evolution (ME) and the maximum-likelihood (ML) methods were used for tree
reconstruction, with starting trees obtained by neighbor joining, followed by use
of a tree-bisection reconnection branch swapping algorithm. The Tajima-Nei
base substitution algorithm was used for ME analysis; estimated general time-
reversible substitution frequencies, corrected for among-site rate variations
(gamma distribution) and a proportion of invariant sites, were used for ML
analysis. Both methods placed the new LLV sequence in the same clade and
produced trees with similar topologies. A bootstrap analysis consisting of 1,000
repetitions was conducted for the distance-based analysis (ME analysis), as
described previously (52).
(iv) Proviral load and tissue distribution. Multiple cell and tissue samples
(PBMCs and liver, spleen, peripheral lymph node, cerebellum, frontal cortex,
parietal lobe, and bone marrow tissues) were collected from lion TT at necropsy.
Lions DJ and EL did not have planned necropsies, and therefore, the harvesting
of tissue for DNA extraction was not conducted. DNA was extracted from each
tissue by using a QIAamp DNA blood mini kit (QIAGEN, Valencia, CA). Serial
10-fold dilutions of DNA from each tissue were made from 1 g to 1 pg. The
nested primers generated from lion TT’s pol sequence were used to amplify a
133-bp sequence in a three-round nested touchdown PCR assay (15, 45, 57) by
using the conditions described below with a Perkin-Elmer Gene Amp PCR
system 9600 thermocycler.
In round 1, the reaction mixture comprised DNA, 0.2 mM deoxynucleoside
triphosphates, 3 mM MgCl2, 4 M each outer primer, and 2.5 mU of Taq
polymerase (Sigma Co., St. Louis, MO) in a final volume of 25 l with 1
reaction buffer (Sigma Co.). Cycling parameters consisted of 1 min at 94°C, 94°C
for 10 s, and 72°C for 20 s and then 2 cycles of 60°C and 48°C for 20 s, followed
by 15 cycles with 45°C extensions for 20 s. In rounds 2 and 3, the reaction mixture
comprised 1 l of the product from the previous round, 0.2 mM deoxynucleoside
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triphosphates, 3.5 mM MgCl2, 4 M each primer, and 2.5 mU of Taq polymerase
(Sigma Co.) in a final volume of 30 l with 1 reaction buffer (Sigma Co.).
Cycling parameters consisted of 1 min 94°C, 94°C for 10 s, and 72°C for 20 s and
then 2 cycles of 60°C and 48°C for 20 s, followed by 10 cycles with 45°C extensions
for 20 s. Titration endpoints were determined for each tissue by evaluating the
lowest dilution that reproducibly amplified a PCR product. The lowest 10-fold
dilution that resulted in an amplified product was then diluted twofold in a serial
manner to more closely determine the dilutional endpoint. Each trial was re-
peated at least twice in duplicate or triplicate, and the same endpoint was
obtained during each trial. Proviral copy numbers per 106 cells were calculated
by assuming that 1 g of DNA was representative of 105 cells. This assay was
determined to be sensitive to between 10 and 100 proviral copies/g DNA by
titration of target plasmid dilutions spiked in 1 g of naı¨ve DNA (data not
shown).
RESULTS
Physical examination and observation. All three LLV-in-
fected lions developed progressive weight loss and mild lymph-
adenopathy over the 3-year course of observation. All infected
lions were found to display periodic “star-gazing” behavior of
various durations. This behavior consisted of motionless star-
ing into the sky with a lack of response to stimuli. Other
behavioral changes found in the LLV-infected lions included
dysphagia, abnormal gait, and ataxia. Periods of lethargy were
also noted. Both lion TT and lion EL displayed a progressive
increase in observed abnormal behavioral scoring during the
course of this study.
Electrodiagnostic examination. LLV-infected lions demon-
strated abnormalities by AEP and QEEG testing. Prolonged
peak-onset latencies of waves III and V and interpeak latencies
compared to the 95% confidence intervals of the values for the
control lions were seen for the AEPs of all LLV-infected lions,
indicating altered brain stem pathway function. The infected
lions also demonstrated an increase in diffuse slow-wave activ-
ity compared to that for the control animals (data not shown).
Neuroimaging. Abnormal MRI findings included patchy
cortical and subcortical white matter asymmetrical hyperinten-
sities of the parietal and temporal lobes on T2-weighted im-
ages (Fig. 1A). Those areas were isointense on the T1-
weighted images and were nonenhancing (Fig. 1B). No mass
effect was present. Sulci were prominent, and there was mild
ex vacuo ventriculomegaly, consistent with cerebrocortical
atrophy (Fig. 1B). These MRI findings were consistent with
chronic encephalopathy from encephalomalacia or enceph-
alitis.
Serology and immunophenotyping. All lions were seroneg-
ative for feline leukemia virus, canine distemper virus, feline
infectious peritonitis virus, Toxoplasma gondii, Neospora cani-
num, and cryptococcosis. The titers of antibodies against LLV
antigens in serum were 1:800 for lion EL and 1:1,600 for lion
TT; control lion sera were negative at 1:50. Lion DJ was not
tested for antibodies to LLV but was positive by an FIV-
specific enzyme-linked immunosorbent assay. All LLV-in-
fected lions demonstrated persistent lymphopenia and abnor-
malities in CD4 and CD8 T-cell counts (Table 1). For lion DJ,
only one sample was evaluated for the T-cell phenotype, and it
was taken just prior to necropsy. This sample had marked
decreases in CD4 and CD8 T-cell counts relative to those
for the LLV-negative controls. Four sequential samples from
lion EL demonstrated normal CD4 T-cell counts but elevated
CD8 T-cells counts. Two samples from lion TT had low
CD4 T-cell counts and normal to high CD8 T-cell counts.
CD4:CD8 ratios averaged less than 2 for all three LLV-posi-
FIG. 1. Imaging reveals changes in the brains of LLV-infected lions. (A) Transverse T2-weighted magnetic resonance image at the level of the
parietal lobes of the brain of lion EL. There are bilateral multiple patchy hyperintensities throughout the parietal and temporal cortex, and these
are most extensive on the right (arrows). Sulci are prominent, and lateral ventricles are mildly enlarged. (B) Transverse T1-weighted magnetic
resonance image from the identical level of the parietal lobes of lion EL’s brain. The corresponding parietal and temporal cortexes are isointense
to slightly hypointense and nonenhancing on T1-weighted images.
VOL. 44, 2006 NEUROLOGIC DISEASE IN LLV INFECTION 4347
 o
n
 O
ctober 21, 2015 by UQ Library
http://jcm.asm.org/
D
ow
nloaded from
 
tive animals, while the mean CD4:CD8 ratio for the LLV-
negative animals was 4.
Postmortem evaluation. (i) Gross pathology. Lion TT pre-
sented in poor body condition, with marked icteric discolora-
tion of the mucous membranes, fat, and viscera. Lion TT had
pronounced splenomegaly and hepatomegaly; and the lion’s
lungs appeared to be congested, while the gastrointestinal tract
appeared to be normal. The brain diplayed meningeal fibro-
sis, mild cortical atrophy of the frontal cortex, and mild
bilateral ventriculomegaly of the third ventricles. In con-
trast, there were no grossly appreciable changes in the
brains of lions EL and DJ and only minor aging-associated
or chronic lesions in other organs, including biliary cysts in
the liver, cataracts, alopecia, multifocal scarring in the
lungs, and a thyroid adenoma in lion EL.
(ii) Micropathology. Neuropathologic abnormalities were
found in all three LLV-seropositive animals but were generally
mild. Severe focal fibrosis of the white matter, presumably of
vascular adventitial origin in the corpus callosum and the ad-
jacent cingulate gyrus, was noted in lion DJ. Lion TT had mild
lymphocytic meningitis with vascular dilation and accumula-
tion of monocytes-macrophages in the vascular lumina. Lion
TT had widespread, but mild, neuronal degeneration and ne-
crosis in the neocortex, accompanied by minimal to mild mi-
crogliosis. In a focally extensive area of the subventricular
neuropil in the left thalamus there was malacia with cavita-
tion, hemorrhage, and infiltration of macrophages (Fig. 2).
Throughout many parts of the brain, but most notably in the
thalamus, there was also perivascular accumulation of hemo-
siderin-containing macrophages, suggestive of an earlier hem-
orrhagic event(s). The histological changes seen in the central
nervous system of lion EL were subtle and comprised vascular
mineralization in the meninges and choroid plexus and mini-
mal to mild myelodegenerative changes in the spinal cord,
including scattered axonal sheath or axonal swelling and rare
axonophagia.
Virology. LLV was not recovered from any in vitro cocul-
tures. However, a 385-bp LLV pol sequence was amplified
from lion TT, and nested primers designed from this fragment
isolated a 133-bp pol sequence from lion EL that was identical
to that from lion TT except at 1 bp. The sequence of a 350-bp
fragment from lion TT was compared to previously published
lion lentivirus sequences of known origin and subtype (52, 53)
and was shown to fall clearly in the FIVPle subtype A clade
(GenBank accession no. AY594655) (Fig. 3). This clade is
widely distributed among free-ranging African lions (52, 53)
and, interestingly, has also been found in captive lions and a
captive snow leopard in Asian zoos (53).
The LLV proviral copy number, as quantified by the three-
round touchdown PCR described in Materials and Methods,
was extremely low in all tissues examined. The liver had the
highest proviral load (837 copies/106 cells). Despite marked
neurologic signs, the brain had very low to undetectable pro-
TABLE 1. CD4 lymphocyte counts and the CD4:CD8 ratio are
altered in LLV-seropositive lions (DJ, EL, TT) compared
with those in LLV-seronegative lions
Liona
Range (mean)
CD4 lymphocyte
count
CD8 lymphocyte
count
CD4:CD8
ratio
DJ (n  1) 162 131 1.2
EL (n  4) 983 (270–1,284) 525 (427–624) 1.9 (0.5–2.1)
TT (n  2) 105 (41–170) 470 (115–826) 0.3 (0.2–0.4)
Control (n  3) 905 (693–1,198) 223 (182–278) 4.0 (3.8–4.2)
a n, number of samples tested.
FIG. 2. Microscopic neuropathology of an LLV-infected lion. Neuropil malacia with cavitation, infiltration of macrophages, and multifocal
hemorrhage in a subventricular area of the left thalamus of lion TT can be seen. Hematoxylin and eosin staining. Bar, 100 m.
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viral levels in samples subjected to multiple amplification at-
tempts (Fig. 4 and 5).
DISCUSSION
The three lions evaluated in this study displayed neurologic
signs of disease both antemortem and postmortem, consistent
with lentiviral neuropathies in other species, including humans
and cats infected with HIV and FIV, respectively (12, 38).
Magnetic resonance images of patients with HIV and FIV
encephalopathy demonstrate cerebral atrophy and white mat-
ter lesions similar to those lesions found in lion EL (8, 10, 39,
43, 47). Similarly, the alterations in the AEP and the QEEG
activities observed in these animals have been noted in humans
with HIV infections and cats with FIV infections (31, 38, 39).
The signs of vascular damage seen in the brains of two lions are
consistent with those seem in the brains of HIV-infected pa-
tients (44) and simian immunodeficiency virus (SIV)-infected
nonhuman primates (H. Bielefeldt-Ohmann et al., unpub-
lished data), although the most typical histopathologic change
seen in humans, multinucleated giant cells resulting from the
fusion of activated macrophages and microglia, was not noted
(12). However, the multiple functional and morphological sim-
ilarities detected suggest that the neuropathologic mechanisms
for the disease documented in these lions are consistent with
lentiviral neuropathy. This is further supported by the fact that
the results of serologic evaluations for a panel of pathogens
associated with feline neurologic disease were negative, while
LLV seropositivity, PCR positivity, and the immunopathology
findings were consistent with active and clinical LLV disease.
Cats chronically infected with FIV (3 years) typically have
PBMC proviral burdens greater than 103 infected cells per
million cells (13). In contrast, lion TT had only slightly more
than 102 proviral copies per million PBMCs at death. Low
proviral levels in the brain suggest an immune-mediated neu-
ropathology rather than a direct effect of the virus. In humans,
lentiviral encephalopathy has been shown to result primarily
from metabolic and inflammatory damage rather than from
viral replication. Microglia have been shown to be an impor-
tant reservoir for HIV, and microglial satellitosis has been
associated with axonal injury (10, 12, 21, 31). The principal
mediator of these effects is the activated mononuclear phago-
cyte (MP; 10, 12, 21, 56). The neurotoxic effects are the result
of the nonspecific inflammation induced by the release of
proinflammatory cytokines, as well as the release of excitatory
amino acids and other chemokines produced by MPs (16, 34).
Additionally, infected astrocytes have decreased glutamate re-
uptake, while further release of glutamate is triggered by the
activated MP (9, 23, 31). The HIV-1 Tat protein induces
monocyte chemoattractant protein 1 expression in astrocytes,
which results in further MP entry into the brain (9, 34, 59). Fas
protein induction in host cells in response to HIV infection
stimulates the further inflammation of astrocytes and acts as an
apoptotic signal to neurons and microglia (23). Ultimately,
these and other pathways result in widespread neuronal injury
and death. Oxidative stress enhances the neurologic damage,
resulting in a severe encephalopathy. Our findings suggest that
even low levels of LLV replication may still ultimately result in
overt fatal disease by a mechanism other than immunosuppres-
sion. This is reminiscent of what has been reported for patients
receiving highly active antiretroviral therapy, who, despite hav-
FIG. 4. Proviral DNA demonstrated by semiquantitative PCR.
Liver from lion TT was collected at necropsy, DNA was extracted, and
a three-round semiquantitative touchdown PCR was performed to
quantify the tissue viral load, as described in the text. The product was
run on an agarose gel, stained with ethidium bromide for visualization,
and photographed. PCR products were detected at a 102.0 dilution of
tissue but not at a 102.5 dilution of tissue. The results for all tissues are
shown. Lane , naı¨ve domestic cat PBMC DNA; lane D, LLV-
infected domestic cat PBMC DNA; lane P, plasmid containing a
fragment of LLV pol; lanes H, water-only controls; lanes with num-
bers, dilution series of DNA used in the reaction.
FIG. 3. Phylogenetic tree of LLV pol RT sequences (350 bp in-
cluded in the analysis). A single minimum-evolution tree estimated by
neighbor joining, with bootstrap support shown for relevant nodes, is
illustrated. Boxed, shaded text designates the sequence isolated from
our study lion; the Ple-n designations indicate sequences obtained
from free-ranging and captive lions. Subtypes A to F, as defined by
Troyer et al. (52), are indicated on the right. FIV Fca and FIV Peta-
luma are two domestic cat FIV strains used as an outgroup.
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ing therapeutically controlled virus loads, develop central and
peripheral neuropathies over time (26, 28, 30).
High titers of anti-LLV antibodies were detected in lions
two lions for which antibodies were titrated, TT and EL. This
is typical of the titers noted in other seropositive lions (S.
VandeWoude, unpublished data). While the neutralizing abil-
ities of these antibodies were not evaluated, the antibody re-
sponse to this virus may have contributed to containment of
the viral load, and it is possible that the robust antibody re-
sponse contributed to immune-mediated damage in the brain.
Anti-HIV type 1 (HIV-1) antibodies increase HIV-1 uptake
into human monocytes and suggest that viral opsonization may
be one mechanism for neuroinvasion in these animals (2); viral
antigen-antibody complement-mediated vascular damage is a
second mechanism recognized in HIV encephalopathy (44).
Consistent with the findings of other studies, we determined
that antibodies recognizing domestic cat CD4, CD5, and CD8
surface antigens bound efficiently to lion PBMCs (5, 6, 22, 46).
While the study described in this report did not use CD4 and
CD8 dual staining, other studies have not identified CD4
CD8 double-positive cells in the circulation, as has been
noted in some subspecies of African Green monkeys resistant
to naturally occurring SIV disease (20, 29). The significant
difference between the ages of the three infected animals and
those of the three control lions may have contributed to the
lymphocyte subset differences observed between the LLV-
seropositive and the LLV-seronegative animals in this study. It
has been difficult to overcome this analytical limitation in stud-
ies of LLV-associated immunopathology, as the majority of
mature lions in captive and free-ranging settings are LLV pos-
itive. In two published reports that have enumerated CD4 and
CD8 in lions, values were reported for five naı¨ve lions aged 2,
3, 9, and unknown numbers of years (46) and five naı¨ve lions
aged 2 to 7 years (6). Both studies noted statistically significant
decreases in CD4 T-cell counts in LLV-seropositive lions, as
well as changes in CD8 T-cell distributions, concurrent with
disease status, consistent with our findings.
The lymphocyte subset profiles observed in the animals in
this study are consistent with immune dysregulation, analogous
to that in HIV and FIV disease.
Interestingly, each lion demonstrated a different pattern of
subsets, consistent with the different phases of AIDS that have
been recognized in humans and cats. Lion DJ demonstrated
severe lymphopenia and depletion of both CD4 and CD8
cells, consistent with end-stage AIDS. Lion EL had relatively
normal CD4 T-cell counts but elevated CD8 T-cell counts,
as might be noted in the steady-state phase of disease. Lion TT
had an intermediate pattern of CD4 T-cell depletion and
elevated CD8 T-cell counts, suggesting that T-cell disease
expression in this animal was not controlled as well as it was in
lion EL. As in HIV and FIV infections, it appears that the
progression of disease in these lions is associated with changes
in CD4 and CD8 T-cell dynamics, although the time to
disease appears to be much longer in lions than in humans or
domestic cats. Ultimately, at least in this cohort, neurologic
disease and not immunodeficiency was the cause of death or
the reason for euthanasia (4, 11, 13, 17, 42, 48).
Multiple attempts to propagate LLV in vitro were unsuc-
cessful. The low proviral load demonstrated in these studies
prompts the question of whether LLV failed to grow due to
a lack of replication-competent virions. It is also possible
that innate restriction factors, such as TRIM5alpha and
APOBEC3G, described in other natural lentiviral hosts pre-
vented the virus from infecting domestic cat cells, although the
virus also failed to grow in PBMCs of lion origin (35). The high
degree of interclade genetic polymorphism among strains sug-
gests that LLV is an ancient lentivirus. Possible host mecha-
nisms that may have evolved to survive viral infection include
effective immunologic control, receptor down regulation, and
intracellular blocks to replication. It is also possible that the
FIG. 5. LLV proviral load in tissues is low during end-stage disease. The LLV proviral DNA copy numbers from tissues collected from lion TT
at necropsy are shown. The proviral DNA copy number per million cells was determined by titrating 1 g of DNA, equivalent to 105 cells, by
semiquantitative PCR with primers that amplified a conserved region of pol, as described in the text. All samples titrated to the same endpoint
during multiple replicates; thus, standard deviation bars have not been included. ln., lymph node.
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virus itself has self-selected over time to favor a disease which
is relatively apathogenic, allowing hosts to live a normal life
span. This situation is similar to that observed for nonpatho-
genic African SIV, which apparently does not cause disease in
native hosts, and may signify the evolutionary outcome of pro-
longed lentiviral-host adaptation (3, 7, 14). Interestingly, sev-
eral case studies of naturally occurring SIV disease in African
monkeys have been recorded and are consistent with our find-
ings that disease occurs only in animals in captivity that have
aged beyond the typical life span of free-ranging animals (24,
27, 33, 49).
This study demonstrates that LLV infection was associated
with neuropathy and immune dysregulation, leading to end-
stage disease in three captive lions. This finding holds signifi-
cant health consequences for free-ranging and captive lions,
given their endangered status and limited ability to outbreed. It
also suggests several new directions for LLV research. It has
already been demonstrated that the inoculation of domestic
cats with LLV provides protection from subsequent FIV type
B infection (54). Determination of the plasma viral load or the
level of tissue viremia relative to the proviral load may be
informative for the transcriptional control of LLV during in-
fection. Similarly, evaluation of the cell types infected by LLV
could direct studies of innate restriction to viral replication and
receptor usage. Studies of LLV both in vivo and in vitro could
therefore provide information about host control and viral
adaptation of lentiviral infection, as well as the correlates of
pathogenesis.
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